Loading organizations...
Loading organizations...
Biopharmaceutical company developing next-generation stem-cell medicines.
Clade Therapeutics has raised $87.0M across 1 funding round.
Clade Therapeutics has raised $87.0M in total across 1 funding round.
Clade Therapeutics has raised $87.0M in total across 1 funding round.
Clade Therapeutics's investors include Martin Murphy, Bristol Myers Squibb, Neil White, Ryan Cinalli.
Clade Therapeutics has raised $87.0M across 1 funding round. Most recently, it raised $87.0M Series A in November 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Nov 3, 2021 | $87.0M Series A | Martin Murphy | Bristol Myers Squibb, Neil White, Ryan Cinalli |